ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 80 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 4.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,231 | -99.9% | 14,100 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $7,050,000 | +88025.0% | 14,100 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | -20.0% | 14,100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $10,000 | -47.4% | 14,100 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $19,000 | -99.9% | 14,100 | 0.0% | 0.00% | -70.0% |
| Q3 2021 | $32,430,000 | -47.6% | 14,100 | 0.0% | 0.01% | -44.4% |
| Q2 2021 | $61,899,000 | – | 14,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 5,307,751 | $3,101,000 | 1.18% |
| TANG CAPITAL MANAGEMENT LLC | 2,000,000 | $1,168,000 | 0.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $4,060,000 | 0.08% |
| Artal Group S.A. | 1,803,858 | $1,054,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 616,402 | $360,000 | 0.05% |
| RA Capital Management | 3,040,885 | $1,776,000 | 0.05% |
| Forefront Analytics, LLC | 92,641 | $58,000 | 0.03% |
| Temasek Holdings (Private) Ltd | 4,319,049 | $2,523,188 | 0.01% |
| FEDERATED HERMES, INC. | 8,309,859 | $4,853,000 | 0.01% |
| Cormorant Asset Management, LP | 256,649 | $150,000 | 0.01% |